Combination therapy for management of pemphigus patients with unexpected therapeutic response to rituximab: A report of five cases

KEY CLINICAL MESSAGE: The immunosuppressant agents should be considered earlier in the course of treatment with rituximab, possibly after the unfavorable response at first cycle of treatment, especially in male patients and those with high BMI. ABSTRACT: Rituximab (RTX) has recently been proposed as...

Descripción completa

Detalles Bibliográficos
Autores principales: Aryanian, Zeinab, Riyaz, Insha Zainab, Balighi, Kamran, Ahmadzade, Ali, Mahmoudi, Hamid Reza, Azizpour, Arghavan, Hatami, Parvaneh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675096/
https://www.ncbi.nlm.nih.gov/pubmed/38028089
http://dx.doi.org/10.1002/ccr3.8208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675096/
https://www.ncbi.nlm.nih.gov/pubmed/38028089
http://dx.doi.org/10.1002/ccr3.8208

Ejemplares similares